Glioblastoma is defined as one of the most fatal types of brain cancer. A large portion of patients diagnosed with this disease lose their lives within 1-1.5 years after diagnosis. The survival rate for five years or more is only 7%. Glioblastoma patients face symptoms such as headaches, memory loss, and changes in thought and behavior.
Harnessing the Power of the Immune System Against This Cancer
Currently, treatments for this disease include surgery, radiation, and chemotherapy. However, these methods generally provide temporary solutions and only alleviate symptoms rather than addressing the root of the disease. Due to the blood-brain barrier limiting the effectiveness of drugs, the body is unable to naturally develop a defense against these cancer cells.
At this point, scientists believe that a treatment method known as immunotherapy could be promising for glioblastoma. Immunotherapy focuses on training the body’s immune system to destroy cancer cells. Research indicates that this treatment can be administered through a special injection into the cerebrospinal fluid. Although there is not yet an approved version, this treatment includes some side effects.
Scientists are collaborating with various experts to develop this treatment in order to find more effective solutions for complex diseases like glioblastoma. It is hoped that these studies will bring revolutionary innovations in cancer treatment.
